Entity Name: | TITAN PHARMACEUTICALS, INC. |
Jurisdiction: | FLORIDA |
Filing Type: | Foreign Profit |
Status: |
Inactive
The business entity is inactive. This status may signal operational issues or voluntary closure, raising concerns about the business's ability to repay loans and requiring careful risk assessment by lenders. |
Date Filed: | 21 Nov 2018 (6 years ago) |
Date of dissolution: | 13 Apr 2021 (4 years ago) |
Last Event: | WITHDRAWAL |
Event Date Filed: | 13 Apr 2021 (4 years ago) |
Document Number: | F18000005336 |
FEI/EIN Number |
943171940
Federal Employer Identification (FEI) Number assigned by the IRS. |
Address: | 400 OYSTER POINT BLVD STE 505, SOUTH SAN FRANCISCO, CA, 94080, US |
Mail Address: | 400 OYSTER POINT BLVD STE 505, SOUTH SAN FRANCISCO, CA, 94080, US |
Place of Formation: | DELAWARE |
Name | Role | Address |
---|---|---|
RUBIN MARC M.D. | Chairman | 400 OYSTER POINT BLVD STE 505, SOUTH SAN FRANCISCO, CA, 94080 |
MACFARLANE M. DAVID | Director | 400 OYSTER POINT BLVD STE 505, SOUTH SAN FRANCISCO, CA, 94080 |
MCNAB JAMES RJR | Director | 400 OYSTER POINT BLVD STE 505, SOUTH SAN FRANCISCO, CA, 94080 |
BHONSLE SUNIL M.D. | President | 400 OYSTER POINT BLVD STE 505, SOUTH SAN FRANCISCO, CA, 94080 |
DEVARNEY KATHERINE B | Vice President | 400 OYSTER POINT BLVD STE 505, SOUTH SAN FRANCISCO, CA, 94080 |
CROWLEY BRIAN | Treasurer | 400 OYSTER POINT BLVD STE 505, SOUTH SAN FRANCISCO, CA, 94080 |
CORPORATION SERVICE COMPANY | Agent | - |
Event Type | Filed Date | Value | Description |
---|---|---|---|
WITHDRAWAL | 2021-04-13 | - | - |
REGISTERED AGENT CHANGED | 2021-04-13 | REGISTERED AGENT REVOKED | - |
REINSTATEMENT | 2019-11-12 | - | - |
REVOKED FOR ANNUAL REPORT | 2019-09-27 | - | - |
Name | Date |
---|---|
Withdrawal | 2021-04-13 |
ANNUAL REPORT | 2020-01-14 |
REINSTATEMENT | 2019-11-12 |
Foreign Profit | 2018-11-21 |
Date of last update: 02 Apr 2025
Sources: Florida Department of State